35772643|t|Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
35772643|a|OBJECTIVE: Mutations in the copper-zinc superoxide dismutase (SOD1) gene cause familial amyotrophic lateral sclerosis (ALS), a progressive fatal neuromuscular disease characterized by motor neurons death and severe skeletal muscle degeneration. However, there is no effective treatment for this debilitating disease, since the underlying cause for the pathogenesis remains poorly understood. Here, we investigated a role of acyl-CoA:lysocardiolipin acyltransferase 1 (ALCAT1), an acyltransferase that promotes mitochondrial dysfunction in age-related diseases by catalyzing pathological remodeling of cardiolipin, in promoting the development of ALS in the SOD1G93A transgenic mice. METHODS: Using SOD1G93A transgenic mice with targeted deletion of the ALCAT1 gene and treated with Dafaglitapin (Dafa), a very potent and highly selective ALCAT1 inhibitor, we determined whether ablation or pharmaceutical inhibition of ALCAT1 by Dafa would mitigate ALS and the underlying pathogenesis by preventing pathological remodeling of cardiolipin, oxidative stress, and mitochondrial dysfunction by multiple approaches, including lifespan analysis, behavioral tests, morphological and functional analysis of skeletal muscle, electron microscopic and Seahorse analysis of mitochondrial morphology and respiration, western blot analysis of the SOD1G93A protein aggregation, and lipidomic analysis of cardiolipin content and acyl composition in mice spinal cord. RESULTS: ALCAT1 protein expression is potently upregulated in the skeletal muscle of the SOD1G93A mice. Consequently, ablation or pharmacological inhibition of ALCAT1 by Dafa attenuates motor neuron dysfunction, neuronal inflammation, and skeletal muscle atrophy in SOD1G93A mice by preventing SOD1G93A protein aggregation, mitochondrial dysfunction, and pathological CL remodeling, leading to moderate extension of lifespan in the SOD1G93A transgenic mice. CONCLUSIONS: ALCAT1 promotes the development of ALS by linking SOD1G93A protein aggregation to mitochondrial dysfunction, implicating Dafa as a potential treatment for this debilitating disorder.
35772643	30	36	ALCAT1	Gene	225010
35772643	47	76	amyotrophic lateral sclerosis	Disease	MESH:D000690
35772643	92	96	SOD1	Gene	20655
35772643	180	184	SOD1	Gene	20655
35772643	197	235	familial amyotrophic lateral sclerosis	Disease	MESH:C531617
35772643	237	240	ALS	Disease	MESH:D000690
35772643	263	284	neuromuscular disease	Disease	MESH:D009468
35772643	333	361	skeletal muscle degeneration	Disease	MESH:D005207
35772643	542	584	acyl-CoA:lysocardiolipin acyltransferase 1	Gene	225010
35772643	586	592	ALCAT1	Gene	225010
35772643	628	653	mitochondrial dysfunction	Disease	MESH:D028361
35772643	657	677	age-related diseases	Disease	MESH:D010024
35772643	719	730	cardiolipin	Chemical	MESH:D002308
35772643	764	767	ALS	Disease	MESH:D000690
35772643	775	783	SOD1G93A	CellLine	CVCL:C0CZ
35772643	795	799	mice	Species	10090
35772643	836	840	mice	Species	10090
35772643	871	877	ALCAT1	Gene	225010
35772643	900	912	Dafaglitapin	Chemical	-
35772643	914	918	Dafa	Chemical	-
35772643	956	962	ALCAT1	Gene	225010
35772643	1037	1043	ALCAT1	Gene	225010
35772643	1047	1051	Dafa	Chemical	-
35772643	1067	1070	ALS	Disease	MESH:D000690
35772643	1144	1155	cardiolipin	Chemical	MESH:D002308
35772643	1179	1204	mitochondrial dysfunction	Disease	MESH:D028361
35772643	1507	1518	cardiolipin	Chemical	MESH:D002308
35772643	1551	1555	mice	Species	10090
35772643	1578	1584	ALCAT1	Gene	225010
35772643	1667	1671	mice	Species	10090
35772643	1729	1735	ALCAT1	Gene	225010
35772643	1739	1743	Dafa	Chemical	-
35772643	1755	1779	motor neuron dysfunction	Disease	MESH:D016472
35772643	1781	1802	neuronal inflammation	Disease	MESH:D007249
35772643	1817	1831	muscle atrophy	Disease	MESH:D009133
35772643	1844	1848	mice	Species	10090
35772643	1893	1918	mitochondrial dysfunction	Disease	MESH:D028361
35772643	1937	1939	CL	Disease	MESH:D002971
35772643	2021	2025	mice	Species	10090
35772643	2040	2046	ALCAT1	Gene	225010
35772643	2075	2078	ALS	Disease	MESH:D000690
35772643	2122	2147	mitochondrial dysfunction	Disease	MESH:D028361
35772643	2161	2165	Dafa	Chemical	-
35772643	Association	MESH:D007249	225010
35772643	Association	MESH:D016472	225010
35772643	Association	MESH:D002308	225010
35772643	Association	MESH:D009133	225010
35772643	Association	MESH:D000690	225010
35772643	Association	MESH:D002308	MESH:D000690
35772643	Association	MESH:C531617	20655
35772643	Association	MESH:D028361	225010
35772643	Association	MESH:D010024	225010
35772643	Association	20655	225010
35772643	Association	MESH:D002971	225010
35772643	Association	MESH:D000690	20655

